Heart Failure with Preserved Ejection Fraction Viewed as a Systemic Inflammatory-Metabolic Condition: Insights from the Cardio-Hepato-Pancreatic Axis - Takeaways - MDSpire

Heart Failure with Preserved Ejection Fraction Viewed as a Systemic Inflammatory-Metabolic Condition: Insights from the Cardio-Hepato-Pancreatic Axis

  • By

  • Han Naung Tun

  • April 28, 2026

  • 0 min

Share

  • 1

    HFpEF accounts for about half of heart failure cases and is increasingly recognized as a systemic inflammatory-metabolic condition.

  • 2

    Traditional heart-centered models of HFpEF fail to explain its association with obesity, diabetes, and systemic inflammation.

  • 3

    The cardio-hepato-pancreatic axis suggests that liver and pancreatic dysfunction contribute to cardiac pathology in HFpEF.

  • 4

    Metabolic dysfunction-associated steatotic liver disease (MASLD) serves as a chronic source of inflammation and cardiovascular risk.

  • 5

    Management of HFpEF should focus on systemic inflammation and metabolic dysregulation rather than solely on ventricular mechanics.

Original Source(s)

Heart Failure with Preserved Ejection Fraction Viewed as a Systemic Inflammatory-Metabolic Condition: Insights from the Cardio-Hepato-Pancreatic Axis

  • by Han Naung Tun

  • April 28, 2026

Related Content

Severe maternal morbidity in patients of advanced maternal age with and without metabolic syndrome

Association of organ dysfunction trajectories and major adverse cardiovascular events using clinical obesity in UK Biobank

Impact of body mass index on outcomes of cardiac rehabilitation: a systematic review and meta-analysis